EW
Edwards Lifesciences Corporation · NYSE
- Sector Health Technology
- Industry Medical Specialties
- Website edwards.com
- Employees(FY) 17300
- ISIN US28176E1082
Performance
+0.5%
1W
-8.21%
1M
-1.75%
3M
+27.9%
6M
+11.59%
YTD
-4.41%
1Y
Profile
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Investment Analysis Report: EW
Overview
In this investment analysis report, we will delve into a detailed examination of the stock EW, focusing on various perspectives such as Valuation, Financial Health, Earnings and Revenue Growth, Profitability, Operating Margin, Operating Cash Flow Analysis, and Capital Expenditure Trends and Efficiency. We ...
Technical Analysis of EW 2024-05-03
Overview:
In the last 5 trading days, the stock price has shown a slight decline from 85.95 to 85.25. Various technical indicators have been analyzed, including trend indicators, momentum indicators, volatility indicators, and volume indicators. These indicators provide insights into the potential future movement of the stock price.
Trend Indica...
Recent News & Updates
- 2024-05-08 17:02
- 2024-05-07 11:40
- 2024-05-06 19:52
- 2024-05-01 21:40
- 2024-05-01 21:35
- 2024-05-01 17:27
- 2024-05-01 09:40
- 2024-05-01 09:35
- 2024-04-30 17:03
- 2024-04-30 10:20
- 2024-04-30 09:00
- 2024-04-30 00:18
- 2024-04-29 14:22
Analyst Report: Edwards Lifesciences Corporation(Morningstar Research)
- 2024-04-29 12:18
- 2024-04-29 12:07
- 2024-04-29 07:23
- 2024-04-27 08:46
- 2024-04-26 23:09
- 2024-04-26 21:53
- 2024-04-26 20:28
Edwards gets Q1 boost as Pascal valve repair sales ramp up(Yahoo Finance)
- 2024-04-26 13:12
- 2024-04-26 11:59
This 'Critical' Business Helped Edwards Lifesciences Offset Its TAVR Miss(Investor's Business Daily)
- 2024-04-26 11:21
- 2024-04-26 11:09
- 2024-04-26 10:54
- 2024-04-26 10:42
- 2024-04-26 10:38
Q1 2024 Edwards Lifesciences Corp Earnings Call(Thomson Reuters StreetEvents)
- 2024-04-26 10:29
- 2024-04-26 04:34
- 2024-04-26 04:31
Page 1 of 10
previousnext